Company Filing History:
Years Active: 2003
Title: Noriyuki H Kawahata: Innovator in Signal Transduction Inhibition
Introduction
Noriyuki H Kawahata is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of signal transduction inhibitors. His work focuses on developing compounds that can effectively inhibit intracellular signal transduction, which is crucial for various therapeutic applications.
Latest Patents
Kawahata holds a patent for "Signal transduction inhibitors, compositions containing them." This invention pertains to compounds designed to inhibit intracellular signal transduction, especially those mediated by molecular interactions involving phosphotyrosine-containing proteins. The patent also covers pharmaceutical compositions that include these compounds, along with methods for their prophylactic and therapeutic administration in both human and veterinary medicine. He has 1 patent to his name.
Career Highlights
Noriyuki H Kawahata is associated with Ariad Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, making him a valuable asset in the pharmaceutical industry.
Collaborations
Kawahata has collaborated with notable colleagues such as Manfred Weigele and Regine Bohacek. These partnerships have likely contributed to the success of his research and the development of innovative solutions in the field.
Conclusion
Noriyuki H Kawahata is a distinguished inventor whose work in signal transduction inhibitors has the potential to revolutionize therapeutic approaches in medicine. His contributions to the field are noteworthy and continue to influence pharmaceutical advancements.